What is the recommended management for a Mallory-Weiss tear?

Mallory-Weiss Tear Management

For actively bleeding Mallory-Weiss tears (oozing or spurting), use endoscopic band ligation or through-the-scope clips rather than epinephrine injection alone; for non-bleeding tears with any stigmata (visible vessels, adherent clots, flat spots, or clean base), do not perform endoscopic hemostatic therapy. 1

Risk Stratification at Index Endoscopy

The critical decision point is whether active bleeding is present:

Active Bleeding (Oozing or Spurting)

• Perform endoscopic hemostasis immediately using mechanical methods 1
• Preferred techniques:
  • Endoscopic band ligation (most efficient for primary hemostasis and preventing rebleeding) 1, 2, 3
  • Through-the-scope clips 1
• Avoid epinephrine injection as monotherapy - it is inferior to mechanical methods 1
• Combination therapy (injection plus clipping) is commonly used in practice 4

Non-Bleeding Tears with Stigmata

This includes tears with:

• Visible vessels
• Adherent clots
• Flat pigmented spots
• Clean-based ulcers

Do NOT perform endoscopic hemostatic therapy 1 - the majority of Mallory-Weiss tears are self-limiting and stop spontaneously 4, 5, 2

Supportive Management

All patients require:

• Hemodynamic support and resuscitation as the primary intervention for most cases 5
• Proton pump inhibitors - logical though not proven in literature 2
• Antiemetics - to prevent further retching/vomiting 2

Clinical Context and Pitfalls

Common pitfall: Over-treating non-bleeding tears. The 2025 Canadian guidelines 1 explicitly recommend against intervention in non-bleeding tears, even with high-risk stigmata, because most cases resolve without intervention. In the German national data, only 13.7% required endoscopic injection and 12.8% required clipping 4, indicating the self-limiting nature of most cases.

Mortality considerations: Overall in-hospital mortality is 2.7% 4. Poor prognostic factors include hypovolemic shock, acute kidney injury, sepsis, need for mechanical ventilation, ARDS, bleeding anemia, and female sex 4. These patients warrant more aggressive initial resuscitation and lower threshold for intervention.

When surgery is needed: Surgical intervention is exceedingly rare (0.1% of cases) 4 and reserved only for failure of endoscopic management with ongoing life-threatening hemorrhage 6.

Algorithmic Approach

1. Resuscitate - IV access, fluids, blood products as needed
2. Urgent endoscopy - within hours of presentation 2
3. At endoscopy:
   • Active bleeding → Band ligation or clips
   • No active bleeding → Observe only, no intervention
4. Post-procedure: PPI, antiemetics, monitor hemodynamics
5. If rebleeding: Repeat endoscopy with mechanical hemostasis
6. Surgery: Only if endoscopic failure with hemodynamic instability

The evidence strongly supports a conservative approach for non-bleeding tears while being prepared for immediate mechanical hemostasis in active bleeding, avoiding the outdated practice of prophylactic treatment of high-risk stigmata.